중환자 호흡 감염에서 반정량적 Procalcitonin 분석 = Semi-quantitative Procalcitonin Assay in Critically ill Patients with Respiratory infections

다국어 초록 (Multilingual Abstract)

Background: Serum procalcitonin level has been considered prognostic during sepsis and septic shock. We investigated the significance of procalcitonin in critically ill patients with respiratory infections. Methods: The patients who had radiographically diagnosed diffuse lung infiltrations were enrolled on a prospective basis. Bronchoalveolar lavage (BAL) fluid for the purpose of quantitative cultures (≥10(4) cfu/mL) was obtained from all patients. Serum procalcitonin levels determined by PCT-Q kit were measured on BAL day and classified as follows; ＜0.5 ng/mL, 0.5∼2.0 ng/mL, 2.0∼10.0 ng/mL and ＞10.0 ng/mL. We analyzed the patient`s characteristics according to outcome; favorable or unfavorable, defined as death. Results: Patients from the following categories were included: medical 17 (47.2%), surgical 9 (25%), and burned 10 (27.8%). APACHE II scores on admission to intensive care unit were 11.5±6.89 and 11 (30.6%) had unfavorable outcomes. A procalcitonin level ≥0.5 ng/mL was in 17 (47.2%) of all. On univariate analysis, the frequencies of burn injury, mechanical ventilation, multiple organ failure, and a procalcitonin level ≥0.5 ng/mL were more often increased in patients with unfavorable outcomes than in those with favorable outcomes (p＜.05). Also, a higher procalcitonin range and ventilator-associated pneumonia (VAP) were more closely associated with an unfavorable outcome (p＜.05). However in multivariate analysis, a strong predictor of unfavorable outcome was burn injury (p＜.05). A procalcitonin level ≥0.5 ng/mL was more sensitive in predicting VAP than unfavorable outcome. Conclusion: A higher procalcitonin level seems to be associated with VAP, but further study is required to know that procalcitonin would be a prognostic marker in critically ill patients with respiratory infections.

참고문헌 (Reference)

1 Chastre J, "Ventilator-associated pneumonia" 165 : 867-903, 2002

2 Aouifi A, "Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients" 28 : 3171-3176, 2000

3 Shirani KZ, "The influence of inhalation injury and pneumonia on burn mortality" 205 : 82-87, 1987

4 Gibot S, "Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia" 350 : 451-458, 2004

5 Nylen ES, "Serum procalcitonin as an index of inhalation injury in burns" 24 : 439-443, 1992

6 Luna CM, "Resolution of ventilator- associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome" 31 : 676-682, 2003

7 Dennesen PJ, "Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia" 163 : 1371-1375, 2001

8 Wanner GA, "Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients" 28 : 950-957, 2000

9 von Heimburg D, "Procalcitonin: a sepsis parameter in severe burn injuries" 24 : 745-750, 1998

10 Luyt CE, "Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia" 171 : 48-53, 2005

11 Jensen JU, "Procalcitonin increase in early identification of critically ill patients at high risk of mortality" 34 : 2596-2602, 2006

12 Dandona P, "Procalcitonin increase after endotoxin injection in normal subjects" 79 : 1605-1608, 1994

13 Oberhoffer M, "Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro" 134 : 49-55, 1999

14 Nylén ES, "Pneumonitis-associated hyperprocalcitoninemia" 312 : 12-18, 1996

15 Clinical Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. CLSI document M100-S18"

16 Vincent JL, "Nosocomial infections in adult intensivecare units" 361 : 2068-2077, 2003

17 Assicot M, "High serum procalcitonin concentrations in patients with sepsis and infection" 341 : 515-518, 1993

18 American Thoracic Society, "Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia" 171 : 388-416, 2005

19 Niederman MS, "Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention" 163 : 1730-1754, 2001

20 Chastre J, "Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia" 152 : 231-240, 1995

21 Mandi Y, "Diagnostic relevance of procalcitonin, IL-6, and sICAM-1 in the prediction of infected necrosis in acute pancreatitis" 28 : 41-49, 2000

22 Meisner M, "Comparison of procalcitonin (PCT) and C-reactive protein(CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS" 3 : 45-50, 1999

23 Ioanas M, "Causes and predictors of nonresponse to treatment of intensive care unit-acquired pneumonia" 32 : 938-945, 2004

24 Duflo F, "Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia" 96 : 74-79, 2002